Cassava Sciences Inc - Asset Resilience Ratio

Latest as of March 2017: 11.92%

Cassava Sciences Inc (SAVA) has an Asset Resilience Ratio of 11.92% as of March 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Cassava Sciences Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$2.10 Million

Cash + Short-term Investments

Total Assets

$17.60 Million

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2017)

This chart shows how Cassava Sciences Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Cassava Sciences Inc assets under control.

Liquid Assets Composition Over Time

This chart breaks down Cassava Sciences Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read SAVA total debt and obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$2.10 Million	11.92%
Total Liquid Assets	$2.10 Million	11.92%

Asset Resilience Insights

Moderate Liquidity: Cassava Sciences Inc has 11.92% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Cassava Sciences Inc Industry Peers by Asset Resilience Ratio

Compare Cassava Sciences Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
ALK-Abelló A/S CO:ALK-B	Biotechnology	0.98%
Mirum Pharmaceuticals Inc NASDAQ:MIRM	Biotechnology	6.89%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	Biotechnology	10.55%

Annual Asset Resilience Ratio for Cassava Sciences Inc (2003–2017)

The table below shows the annual Asset Resilience Ratio data for Cassava Sciences Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2017-12-31	0.00%	$0.00	$10.83 Million	--
2016-12-31	10.87%	$2.10 Million	$19.30 Million	+8.38pp
2013-12-31	2.49%	$1.25 Million	$50.10 Million	-9.64pp
2012-12-31	12.13%	$6.90 Million	$56.86 Million	-13.12pp
2011-12-31	25.25%	$24.99 Million	$98.96 Million	-61.88pp
2010-12-31	87.13%	$86.43 Million	$99.19 Million	+10.23pp
2009-12-31	76.90%	$139.97 Million	$182.00 Million	+57.81pp
2008-12-31	19.10%	$36.94 Million	$193.44 Million	-37.98pp
2007-12-31	57.08%	$118.50 Million	$207.62 Million	-33.12pp
2006-12-31	90.19%	$188.01 Million	$208.46 Million	+35.98pp
2005-12-31	54.22%	$117.00 Million	$215.79 Million	-42.64pp
2004-12-31	96.86%	$98.02 Million	$101.19 Million	+15.63pp
2003-12-31	81.23%	$65.40 Million	$80.51 Million	--

pp = percentage points

About Cassava Sciences Inc

NASDAQ:SAVA USA Biotechnology

Market Cap

$58.21 Million

Market Cap Rank

#21427 Global

#4819 in USA

Share Price

$1.21

Change (1 day)

-6.23%

52-Week Range

$1.21 - $4.64

All Time High

$135.30